Structural and functional changes in heparan sulfate proteoglycan expression associated with the myofibroblastic phenotype

American Journal of Pathology

Volumn 162, Issue 3, 2003, Pages 977-989

  Thomas, Gareth ^a   Clayton, Aled ^a   Thomas, Janet ^a   Davies, Malcolm ^a   Steadman, Robert ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISACCHARIDE; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HEPARIN LYASE; NITROUS ACID; PLATELET DERIVED GROWTH FACTOR; PRONASE; PROTEOHEPARAN SULFATE; SODIUM HYDROXIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; ENZYME MECHANISM; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; SULFATION;

EID: 0037369185     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63892-8     Document Type: Article

References (66)

1. Badid C, Mounier N, Costa AM, Desmouliere A: Role of myofibroblasts during normal tissue repair and excessive scarring: interest of their assessment in nephropathies. Histol Histopathol 2000, 15:269-280
2. Badid C, Vincent M, Fouque D, Laville M, Desmouliere A: Myofibroblast: a prognostic marker and target cell in progressive renal disease. Ren Fail 2001, 23:543-549
3. Desmouliere A: Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int 1995, 19:471-476
4. Desmouliere A, Gabbiani G: Myofibroblast differentiation during fibrosis. Exp Nephrol 1995, 3:134-139
5. Desmouliere A, Tuchweber B, Gabbiani G: Role of the myofibroblast differentiation during liver fibrosis. J Hepatol 1995, 22:61-64
6. Phan SH, Zhang K, Zhang HY, Gharaee-Kermani M: The myofibroblast as an inflammatory cell in pulmonary fibrosis. Curr Top Pathol 1999, 93:173-182
7. Vaquero E, Molero X, Tian X, Salas A, Malagelada JR: Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats. Gut 1999, 45:269-277
8. Clayton A, Steadman R, Williams JD: Cells isolated from the human cortical interstitium resemble myofibroblasts and bind neutrophils in an ICAM-1-dependent manner. J Am Soc Nephrol 1997, 8:604-615
9. Clayton A, Steadman R: ICAM-1 interactions in the renal interstitium: a novel activator of fibroblasts during nephritis. Histol Histopathol 1999, 14:861-870
10. Muller GA, Rodemann HP: Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am J Kidney Dis 1991, 17:680-683
11. Rodemann HP, Muller GA: Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 1991, 17:684-686
12. Fine LG, Ong AC, Norman JT: Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 1993, 23:259-265
13. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994, 5:1273-1287
14. Lewis MP, Fine LG, Norman JT: Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells. Kidney Int 1996, 49:48-58
15. Goumenos DS, Brown CB, Shortland J, el Nahas AM: Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 1994, 9:1418-1425
16. Zhang G, Moorhead PJ, el Nahas AM: Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995, 3:308-318
17. Norman JT, Fine LG: Progressive renal disease: fibroblasts, extracellular matrix, and integrins. Exp Nephrol 1999, 7:167-177
18. Coutts JC, Gallagher JT: Receptors for fibroblast growth factors. Immunol Cell Biol 1995, 73:584-589
19. Gallagher JT: Heparan sulphate and protein recognition. Binding specificities and activation mechanisms. Adv Exp Med Biol 1995, 376:125-134
20. Gallagher JT: Structure-activity relationship of heparin sulphate. Biochem Soc Trans 1997, 25:1206-1209
21. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E: Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994, 302:527-534
22. Humes HD, Nakamura T, Cieslinski DA, Miller D, Emmons RV, Border WA: Role of proteoglycans and cytoskeleton in the effects of TGF-beta 1 on renal proximal tubule cells. Kidney Int 1993, 43:575-584
23. Lyon M, Gallagher JT: Hepatocyte growth factor/scatter factor: a heparan sulphate-binding pleiotropic growth factor. Biochem Soc Trans 1994, 22:365-370
24. Lyon M, Rushton G, Gallagher JT: The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J Biol Chem 1997, 272:18000-18006
25. Lyon M, Deakin JA, Rahmoune H, Fernig DG, Nakamura T, Gallagher JT: Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate. J Biol Chem 1998, 273:271-278
26. Lyon M, Gallagher JT: Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol 1998, 17:485-493
27. Aviezer D, Levy E, Safrant M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A: Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 1994, 269:114-121
28. Fernig DG, Gallagher JT: Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 1994, 5:353-377
29. Gallagher JT: Heparan sulphates as membrane receptors for the fibroblast growth factors. Eur J Clin Chem Clin Biochem 1994, 32:239-247
30. Steinfeld R, Van Den Berghe H, David G: Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 1996, 133:405-416
31. Jayson GC, Vives C, Paraskeva C, Schofield K, Coutts J, Fleetwood A, Gallagher JT: Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int J Cancer 1999, 82:298-304
32. Guimond SE, Turnbull JE: Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides. Curr Biol 1999, 9:1343-1346
33. Rapraeger A, Krufla A, Olwin BB: Requirement of heparin sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252:1705-1708
34. Bernfield M, Kokenyesi R, Kato M, Spring MT, Gallo J, Lose E: Biology of the syndecans: a family of transmembrane heparan sulphate proteoglycans. Annu Rev Cell Biol 1992, 8:365-393
35. Abboud HE: Growth factors in glomerulonephritis. Kidney Int 1993, 43:252-257
36. Kim CW, Goldberger OA, Gallo RL, Bernfield M: Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 1994, 5:797-805
37. Bonneh-Barkay D, Shlissel M, Berman B, Shaoul E, Admon A, Vlodavsky I, Carey DJ, Asundi VK, Reich-Slotky R, Ron D: Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J Biol Chem 1997, 272:12415-12421
38. Clayton A, Thomas J, Thomas GJ, Davies M, Steadman R: Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2. Kidney Int 2001, 59:2084-2094
39. Thomas GJ, Jenner L, Mason RM, Davies M: Human glomerular epithelial cell proteoglycans. Arch Biochem Biophys 1990, 278:11-20
40. Thomas GJ, Bayliss MT, Harper K, Mason RM, Davies M: Glomerular mesangial cells in vitro synthesize an aggregating proteoglycan immunologically related to versican. Biochem J 1994, 302:49-56
41. Thomas GJ, Shewring L, McCarthy KJ, Couchman JR, Mason RM, Davies M: Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium. Kidney Int 1995, 48:1278-1289
42. Wasteson A: A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. J Chromatogr 1971, 59:87-97
43. Shively JE, Conrad HE: Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 1976, 15:3932-3942
44. Shively JE, Conrad HE: Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures. Biochemistry 1976, 15:3943-3950
45. Lyon M, Deakin JA, Gallagher JT: Uver heparan sulfate structure. A novel molecular design. J Biol Chem 1994, 269:11208-11215
46. Maccarana M, Casu B, Lindahl U: Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor [published erratum appears in J Biol Chem 1994 Feb 4;269(5):3903]. J Biol Chem 1993, 268:23898-23905
47. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC: Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 1993, 268:23906-23914
48. Walker A, Turnbull JE, Gallagher JT: Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem 1994, 269:931-935
49. Ishihara M: Function and structure of heparan sulfate - modification of FGF activities. Tanpakushitsu Kakusan Koso 1995, 40:1122-1133
50. Herr AB, Ornitz DM, Sasisekharan R, Venkataraman G, Waksman G: Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes. J Biol Chem 1997, 272:16382-16389
51. Moy FJ, Safran M, Seddon AP, Kitchen D, Bohlen P, Aviezer D, Yayon A, Powers R: Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. Biochemistry 1997, 36:4782-4791
52. DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J, Hendrickson WA: Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 1998, 393:812-817
53. Gallagher JT: Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 2001, 108:357-361
54. Brickman YG, Ford MD, Small DH, Bartlett PF, Nurcombe V: Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells. J Biol Chem 1995, 270:24941-24948
55. Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE: Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 1998, 273:4350-4359
56. Brickman YG, Nurcombe V, Ford MD, Gallagher JT, Bartlett PF, Turnbull JE: Structural comparison of fibroblast growth factor-specific heparan sulfates derived from a growing or differentiating neuroepithelial cell line. Glycobiology 1998, 8:463-471
57. Green PJ, Walsh FS, Doherty P: Promiscuity of fibroblast growth factor receptors. Bioessays 1996, 18:639-646
58. Klint P, Claesson-Welsh L: Signal transduction by fibroblast growth factor receptors. Front Biosci 1999, 4:D165-D177
59. Szebenyl G, Fallon JF: Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999, 185:45-106
60. Kan M, Wang F, To B, Gabriel JL, McKeehan WL: Divalent cations and heparin/heparan sulfate cooperate to control assembly and activity of the fibroblast growth factor receptor complex. J Biol Chem 1996, 271:26143-26148
61. Krufka A, Guimond S, Rapraeger AC: Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation. Biochemistry 1996, 35:11131-11141
62. Mundhenke C, Meyer K, Drew S, Friedl A: Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 2002, 160:185-194
63. Berman B, Ostrovsky O, Shlissel M, Lang T, Regan D, Vlodavsky I, Ishai-Michaeli R, Ron D: Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor. J Biol Chem 1999, 274:36132-36138
64. Couchman JR, Woods A: Syndecans, signaling, and cell adhesion. J Cell Biochem 1996, 61:578-584
65. Woods A, Longley RL, Tumova S, Couchman JR: Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch Biochem Biophys 2000, 374:66-72
66. Couchman JR, Chen L, Woods A: Syndecans and cell adhesion. Int Rev Cytol 2001, 207:113-150